Bio-Techne

🎙️ Heart disease is the leading cause of death worldwide, but Dr. Doris Taylor is changing the game with her bioengineered hearts. In this episode #BackOfTheNapkin, https://apple.co/3D1Y4mN and https://bit.ly/49t3y6n, Doris shares her inspiring journey and discusses her groundbreaking advancements in regenerative medicine, including the development of the first bioartificial heart. Tune in to experience this compelling story of innovation and perseverance! #HeartDisease #RegenerativeMedicine #Bioengineering

🎙️ Listen Now: https://apple.co/3D1Y4mN & https://bit.ly/4f9TNLu "The first life we save will change everything." - Doris Taylor With heart disease as the leading cause of death, the need for viable heart transplants is more urgent than ever. Dr. Doris Taylor’s pioneering work developing the first beating bioartificial heart offers hope for countless patients awaiting life-saving transplants. In this episode of #BackofTheNapkin, Doris shares her journey from personal motivations to her groundbreaking achievements in regenerative medicine. Key Takeaways: • Development of the first beating bioartificial heart. • Addressing the unmet need for donor hearts. • Revolutionizing transplant medicine with innovative techniques. Be inspired by Doris’s journey in science! #RegenerativeMedicine #Bioengineering #HeartDisease

Streamline experiments and cut costs with a single recombinant protein that stimulates the Wnt signaling pathway. Read the App Note https://bit.ly/4fp39D6

🎙️ Listen Now: https://apple.co/3D1Y4mN & https://bit.ly/3VLMClY With heart disease as the world’s leading cause of death, Dr. Doris Taylor is offering new hope through her groundbreaking work in bioengineering hearts. Tune into Back of the Napkin to hear Dr. Taylor share her inspiring journey and the cutting- edge science behind the first beating bioartificial heart, a milestone in regenerative medicine. Don’t miss this inspiring episode—discover the future of heart transplants! #BackOfTheNapkin #BioTechne #HeartDisease #Innovation #SciencePodcast #RegenerativeMedicine #Bioengineering #TransplantInnovation #Cardiology

How do charge variants impact the binding kinetics of a biotherapeutic? Our latest application note, developed in collaboration with Nicoya, uncovers the answer by using an innovative workflow that combines icIEF fractionation on the MauriceFlex™ system and SPR analysis on the Alto™ System (Nicoya). This approach allowed us to analyze the binding behavior of individual charge variants in a therapeutic bispecific antibody and a research-grade biosimilar. The findings are fascinating - learn more in the application note!    Download: https://bit.ly/3Bsikh7   #Biotherapeutics #BindingKinetics #ProteinCharacterization #icIEF #SPR

🎙️ Dive into this episode of Back of the Napkin and listen now https://apple.co/3OgetGu & https://bit.ly/3ZaxS0C, where Professor Kevan Shokat reveals the pivotal moments that have shaped his career. Hear the story behind targeting the so-called "undruggable" KRAS and discover the new challenges that have captured Kevan’s focus. Learn how his work in drug discovery is revolutionizing cancer treatment. Key Takeaways: ▪️ Kevan's career blends chemistry and biology to tackle ‘impossible’ challenges like targeting "undruggable" proteins. ▪️ Success comes from breaking complex problems into manageable steps. ▪️ Collaboration is central to advancing scientific research. Get inspired by Kevan’s journey in science! #BackOfTheNapkin #BioTechne #CancerTherapy #Innovation #KRAS #SciencePodcast #DrugDiscovery #OncologyResearch #KRASInhibitors

🎙️ Listen Now: https://apple.co/3OgetGu and https://bit.ly/4fKutN4 Curious about how a scientist tackled the "undruggable"? Listen to this episode of Back of the Napkin as Kevan Shokat reveals the groundbreaking stories behind his innovative work targeting KRAS and his pioneering career in drug discovery. Tune in now to discover how Kevan Shokat is transforming cancer treatment! #BackOfTheNapkin #BioTechne #CancerTherapy #Innovation #KRAS #SciencePodcast #DrugDiscovery #KRASInhibitors #OncologyResearch #CancerResearch

🎙️ Listen Now: https://apple.co/3ZsMs43 and https://bit.ly/3Z7JIZF “Wherever chemical biology is going to go, it’s going to be fast!” – Laura Kiessling Hear how Laura Kiessling, Novartis Professor of Chemistry at MIT, is advancing chemical biology with her groundbreaking research on carbohydrates and infectious diseases. Don’t miss this inspiring episode of Back of the Napkin! #BackOfTheNapkin #BioTechne #WomenInScience #ChemicalBiology #Glycotime #SciencePodcast

A range of convenient and ready-to-use reagents in solution to save time on your stem cell culture and CGT workflows. Choose from CHIR 99021, LDN 193189, and ROCK inhibitor Y-27632 in 10 mM sterile-filtered solution. Learn more: https://bit.ly/3ZKVf2o

🎙️ Listen Now: https://apple.co/3VaLQPb and https://bit.ly/3OscdMD "KRAS is not "undruggable." Kevan M. Shokat is breaking new ground in cancer therapy. Join us on this episode of Back of the Napkin as Kevan shares the inspiring stories behind his groundbreaking work targeting the KRAS protein, once thought to be ‘undruggable.’ Kevan’s innovative research is revolutionizing cancer treatment and driving new opportunities for scientific collaboration. #BackOfTheNapkin #BioTechne #CancerTherapy #Innovation #KRAS #SciencePodcast #DrugDiscovery #OncologyResearch #KRASInhibitors